Retinitis Pigmentosa
Cross-source consensus on Retinitis Pigmentosa from 1 sources and 3 claims.
1 sources · 3 claims
Benefits
Evidence quality
Highlighted claims
- Most studies on RP therapies had moderate risk of bias, and the evidence was moderate to low quality due to statistical and methodological heterogeneity. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review
- A review of emerging therapies for retinitis pigmentosa found only small improvements in visual acuity along with adverse events. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review
- Therapies for RP show potential for slowing disease progression and preserving visual function, but further robust studies are required. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review